awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26859114-CF2A682F-5431-4E60-851D-C4A944A5558E
Q26859114-CF2A682F-5431-4E60-851D-C4A944A5558E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26859114-CF2A682F-5431-4E60-851D-C4A944A5558E
Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder
P2860
Q26859114-CF2A682F-5431-4E60-851D-C4A944A5558E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26859114-CF2A682F-5431-4E60-851D-C4A944A5558E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3c37af866b2a88a08150e28a2cc11c6dff3fb223
P2860
Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer.